Trial Profile
Immunogenicity and Safety Study of Kinrix co-Administered With Varivax.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jul 2023
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; Measles mumps and rubella virus vaccine (Primary) ; Varicella zoster virus vaccine live (Primary)
- Indications Chickenpox; Diphtheria; Measles; Mumps; Pertussis; Poliomyelitis; Rubella; Tetanus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 02 Feb 2010 Actual patient number (478) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.